The Government of the Grand Duchy of Luxembourg

COVID-19 archives

Recommendation on Covid-19 booster vaccination for autumn 2023 (Pdf, 863 Kb) (CSMI recommendation dated 26 September 2023)
Recommendation on a second COVID-19 booster dose (Pdf, 994 Kb) (CSMI updated recommendation of 6 March 2023)
Recommendation on first-time vaccination with bivalent COVID-19 vaccines (Pdf, 724 Kb) (CSMI recommendation dated 27 February 2023)

CSMI recommendations on COVID-19 vaccination of children aged six months to five years (Pdf, 1.12 Mb) (CSMI recommendation dated 29 November 2022)

CSMI recommendation on COVID-19 and pregnancy (Pdf, 763 Kb) (CSMI recommendation dated 19 October 2022)

Recommendation on a fourth COVID-19 vaccine dose for individuals aged 60 and over (Pdf, 868 Kb) (CSMI recommendation dated 14/07/2022)
Recommendation on a fourth COVID-19 vaccine dose (Pdf, 666 Kb) (CSMI recommendation dated 12/04/2022)

COVID-19 vaccination of pregnant and breastfeeding women (Pdf, 712 Kb) (CSMI recommendation dated 21 March 2022)

COVID-19 patients (Pdf, 683 Kb) (infected with SARS-CoV-2: duration of isolation (CSMI recommendation dated 21 March 2022)

Resumption of the COVID-19 vaccination plan (French, Pdf, 694 Kb) following interruption (CSMI recommendation dated 3 March 2022)

Shortening the interval between first-time COVID-19 vaccination and the booster vaccination (Pdf, 729 Kb) (update of 3 March 2022)

Novavax NuvaxovidR COVID-19 vaccine (Pdf, 748 Kb)(CSMI recommendation dated 25 February 2022)

COVID-19 vaccination (Pdf, 820 Kb) of children aged five to eleven years (update of 6 January 2022)

Recommendation (Pdf, 773 Kb) on SARS-CoV-2 booster vaccination following first-time vaccination (CSMI recommendation dated 14 December 2021)

COVID-19 vaccination (Pdf, 778 Kb) of children aged five to eleven years (CSMI recommendation dated 29 November 2021)

Recommendations (Pdf, 769 Kb) on SARS-CoV-2 booster vaccination following first-time vaccination (CSMI recommendation dated 9 November 2021)

Optimal dose of messenger RNA vaccine (Pdf, 703 Kb) following COVID-19 vaccination with the Janssen vaccine (CSMI recommendation dated 14 October 2021)

Simultaneous administration (Pdf, 774 Kb) of COVID-19 and seasonal influenza vaccines (CSMI opinion dated 7 October 2021)

Screening (Pdf, 717 Kb) in facilities providing medical and social care services, and in homes for the elderly providing medical and social care services (CSMI recommendation dated 18 August 2021)

Second COVID-19 vaccine dose (Pdf, 730 Kb) for persons with a contraindication to the Vaxzevria vaccine (CSMI recommendation dated 08/07/2021)

Third COVID-19 vaccine dose (Pdf, 713 Kb) in immunosuppressed individuals (recommendation dated 02/07/2021)
Second COVID-19 vaccine dose (Pdf, 709 Kb) for persons with a contraindication to the Vaxzevria vaccine (CSMI recommendation dated 18 June 2021)

Vaccination (Pdf, 719 Kb) following COVID-19 infection (CSMI recommendation dated 10 June 2021, corrected on 16 June 2021)

COVID-19 vaccination (Pdf, 849 Kb) of young people aged 12 to 18 years (update of 17 August 2021)

Johnson&Johnson's JCOVDEN COVID-19 vaccine (Pdf, 744 Kb) (CSMI opinion dated 30 April 2021)

Thrombocytopenia and thrombosis (Pdf, 4.41 Mb) following COVID-19 vaccination (CSMI recommendation dated 23 April 2021)

Thromboembolic risks (Pdf, 974 Kb) following COVID-19 vaccination (CSMI opinion dated 16 April 2021)

COVID 19 vaccination strategy (Pdf, 759 Kb) in Luxembourg – phase 2 and subsequent phases (update of 29 March 2021)

AstraZeneca COVID-19 vaccine (Pdf, 777 Kb) (update of 02/03/2021)

Comirnaty COVID-19 vaccine (Pdf, 714 Kb) (CSMI recommendation dated 15/01/2021)

AstraZeneca COVID-19 vaccine (Pdf, 639 Kb) (update of 16/02/2021)

AstraZeneca COVID-19 vaccine (Pdf, 806 Kb) (CSMI recommendation dated 04/02/2021)

COVID 19 vaccination strategy (Pdf, 759 Kb) in Luxembourg – Phase 2 and subsequent phases (CSMI opinion dated 28/01/2021)

Moderna COVID-19 vaccine (Pdf, 878 Kb) (CSMI recommendation dated 20/01/2021)

Wearing facemasks (Pdf, 702 Kb) in class (CSMI recommendation dated 6 January 2021)

Comirnaty COVID-19 vaccine (Pdf, 802 Kb) (CSMI recommendation dated 6 January 2021)

Communication on public health measures (Pdf, 647 Kb) (CSMI communication dated 5 January 2021)

Communication on public health measures (Pdf, 525 Kb) (CSMI communication dated 16 December 2020)

Use of antigen tests (Pdf, 869 Kb) to detect the SARS-CoV-2 virus (CSMI recommendation dated 29 October 2020)

COVID-19 and pregnancy (Pdf, 716 Kb) (CSMI recommendation dated 1 October 2020)

COVID-19 strategy (Pdf, 692 Kb) and children under the age of four (CSMI recommendation dated 21 September 2020)

COVID-19 vaccination strategy (Pdf, 676 Kb) (CSMI recommendation dated 22/09/2020)

Protocol for managing patients (Pdf, 3.33 Mb) with confirmed or suspected COVID-19 infection (CSMI recommendation dated 02/04/2020)

Persons with a high risk (Pdf, 671 Kb) of COVID-19 (CSMI recommendation dated 25 April 2020)

Children with a high risk (Pdf, 669 Kb) of COVID-19 (CSMI recommendation dated 25 April 2020)

Last update 07.01.2026

Back to top